Mirova Moderna, Inc. Transaction History

Mirova

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$69.51 - $104.43 $3,058 - $4,594	-44 Reduced 5.61%	741 $73,000
Q3 2023 Nov 14, 2023	SELL	$96.41 - $126.61 $122,826 - $161,301	-1,274 Reduced 61.87%	785 $81,000
Q2 2023 Aug 11, 2023	SELL	$118.5 - $160.53 $262,122 - $355,092	-2,212 Reduced 51.79%	2,059 $250,000
Q1 2023 May 12, 2023	BUY	$135.66 - $197.02 $337,522 - $490,185	2,488 Added 139.54%	4,271 $655,000
Q4 2022 Feb 13, 2023	SELL	$118.38 - $210.04 $211,071 - $374,501	-1,783 Reduced 50.0%	1,783 $320,000
Q3 2022 Nov 14, 2022	SELL	$118.07 - $194.18 $295,529 - $486,032	-2,503 Reduced 41.24%	3,566 $421,000
Q2 2022 Aug 12, 2022	SELL	$117.13 - $176.59 $425,650 - $641,728	-3,634 Reduced 37.45%	6,069 $866,000
Q1 2022 May 13, 2022	SELL	$126.46 - $235.05 $29,591 - $55,001	-234 Reduced 2.35%	9,703 $1.67 Million
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $2.24 Million - $3.66 Million	9,937 New	9,937 $2.52 Million

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Mirova, based on Form 13F filings with the SEC.

Stay updated on Mirova with notifications on news.